The group’s principle activity is to provide customized bioanalytical method development and sample analysis services to its global client base. The group also provides customized scientific services relevant to drug efficacy, toxicity, and disease through the application of cutting edge knowledge and expertise in the disciplines of biotechnology, proteomics and genomics. The group’s services include sample analysis and core research services. The group operates from United States.
